Recall: D-0223-2024

Class II - Potentially Harmful

Class IIClassification

2024-01-02Initiated

CompletedStatus

Dr. Reddy's Laboratories, Inc.Firm

Product

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

Reason

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Distribution

USA Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.